Key facts
- This page summarizes Mary E. Wright's Form 3 filing for Inogen Inc (INGN).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 07 Aug 2025, 16:32.
Mary E. Wright - 28 Jul 2025 Form 3 Insider Report for Inogen Inc (INGN)
- Reporting relationship
- VP, Chief Accounting Officer
- Issuer ticker
- INGN
- Reported as of
- 28 Jul 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 07 Aug 2025, 16:32:10 UTC
- Next SEC filing
- 03 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mary Wright
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mary E. Wright filed Form 3 for Inogen Inc (INGN) on 07 Aug 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002079955
Primary reporting owner
Wright Mary E
- Relationship
- VP, Chief Accounting Officer
- Address
- C/O INOGEN, INC., 859 WARD DRIVE, GOLETA
- Signature
- /s/ Mary Wright
- Signature date
- 07 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 12,180
- Date
- 28 Jul 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INGN
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,755
- Exercise price
- $0.000000
- Footnotes
- F2, F3
INGN
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,499
- Exercise price
- $0.000000
- Footnotes
- F2, F4
INGN
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,003
- Exercise price
- $0.000000
- Footnotes
- F2, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Includes 60 shares of Inogen Common Stock acquired pursuant to Inogen's Employee Stock Purchase Plan ("ESPP").
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
Footnote F3
Subject to the reporting person's continued service, the restricted stock units shall vest on March 1, 2026.
Footnote F4
Subject to the reporting person's continued service, the restricted stock units shall vest on March 1, 2027.
Footnote F5
Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from March 1, 2025 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.
SEC remarks
Exhibit 24 - Power of Attorney.